Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For SNV
Valuation Somewhat Weak
43%
Profitability n.A.
Fin. Growth Positive
83%
Leverage & Liquidity Bad
0%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -100.00 0.17 3490.49
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 52.90 -0.94 -2.01
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value -2.03 34.27 34.98
Cash -0.64 82.46 82.99
Capex -58.65 -0.13 -0.08
Free Cash Flow -66.05 0.55 1.63
Revenue 103.02 6.15 3.03
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 11.23 0.91 0.82
Operating Margin -40.05 0.21 0.35
ROA 76.93 < 0.005 < 0.005
ROE 80.61 0.02 0.01
ROIC 15.71 0.02 0.02
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of SNV is permitted for members.
5 Growth
The "Growth Entry" for the Focus of SNV is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of SNV is permitted for members.